L086-1455 Screening compound: N-[(E)-N'-(4-chloro-2-methylphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide

L086-1455 Screening compound: N-[(E)-N'-(4-chloro-2-methylphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide
L086-1455 Screening compound: N-[(E)-N'-(4-chloro-2-methylphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L086-1455
N-[(E)-N'-(4-chloro-2-methylphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L086-1455

Molecular Formula

C24H25ClN4O4 (C24 H25 ClN4 O4)

Compound Name

N-[(E)-N'-(4-chloro-2-methylphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide

IUPAC name

N-[(E)-N'-(4-chloro-2-methylphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]-345-trimethoxybenzamide

SMILES

Cc(cc(cc1)Cl)c1/N=C(\NCc1ncccc1)/NC(c(cc1OC)cc(OC)c1OC)=O

InChI

InChI=1S/C24H25ClN4O4/c1-15-11-17(25)8-9-19(15)28-24(27-14-18-7-5-6-10-26-18)29-23(30)16-12-20(31-2)22(33-4)21(13-16)32-3/h5-13H,14H2,1-4H3,(H2,27,28,29,30)

InChI Key

RCRWTUCKLUQVJU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27230228

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.94

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.247

Distribution Coefficient, logD

3.910

Water Solubility, LogSw

-4.53

Polar Surface Area

73.675

Acid Dissociation Constant (pKa)

11.81

Base Dissociation Constant (pKb)

7.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

L086-1455 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L086-1455 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L086-1455?
Check Price and Availability of L086-1455, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L086-1455 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L086-1455
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L086-1455
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L086-1455 available by request